Get the Stockscreener App
5.15
0.98%
0.05
Bionexus Gene Lab Corp stock is traded at $5.15, with a volume of 8,416.
It is up +0.98% in the last 24 hours and up +87.96% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$5.10
Open:
$5.16
24h Volume:
8,416
Relative Volume:
0.01
Market Cap:
$9.25M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-71.53
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
+21.18%
1M Performance:
+87.96%
6M Performance:
+49.58%
1Y Performance:
+4.02%
1-Day Range:
$5.1008
$5.19
1-Week Range:
$4.51
$7.05
52-Week Range:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.56 | 689.87M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.70 | 117.84M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1599 | 317.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3733 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
What drives BioNexus Gene Lab Corp. stock priceFree Investment Case Studies - jammulinksnews.com
What analysts say about BioNexus Gene Lab Corp. stockExponential return rates - jammulinksnews.com
BioNexus Gene Lab Corp. Stock Analysis and ForecastExponentially increasing returns - jammulinksnews.com
Is BioNexus Gene Lab Corp. a good long term investmentOutstanding investment returns - jammulinksnews.com
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Why BioNexus Gene Lab Corp. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser
What makes BioNexus Gene Lab Corp. stock price move sharplySmart Growth Low Risk Picks - Newser
How BioNexus Gene Lab Corp. stock performs during market volatilityLong Term Safe Yield Focus - Newser
why bglc surge today? - AInvest
Bglc news today - AInvest
What are the pros and cons of investing in BGLC? - AInvest
Why did BGLC surge? - AInvest
Why did BGLC plummet? - AInvest
US Stocks Mixed; UniFirst Shares Fall After Q3 Results - Benzinga
Pre-market Movers: BGLC, TIL, CNC, MBIO... - RTTNews
BGLC stock surged: what’s going on with BioNexus Gene Lab Corp? - Markets.com
US Stocks Mixed; Dow Gains Over 50 Points - Benzinga
BGLC Shares Soar: Is It Time to Invest? - timothysykes.com
Thumzup Media Shares Jump 20.4% After $6.5M Registered Direct Offering, 20 Stocks Moving in Premarket Trading - AInvest
Is BioNexus Gene Lab Corp. technically bullish or bearish? - MarketsMojo
BioNexus Gene Lab Appoints New Chief Financial Officer - TipRanks
BioNexus Gene Lab Corp Regains Nasdaq Compliance With $1.00 Minimum Bid Price - marketscreener.com
Bionexus Gene Lab regains Nasdaq compliance - TipRanks
BioNexus Gene Lab regains Nasdaq compliance By Investing.com - Investing.com India
BioNexus Gene Lab regains Nasdaq compliance - Investing.com
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness - The Manila Times
BioNexus Gene Lab Corp. Regains Compliance with Nasdaq Listing Rule and Enhances Growth Strategy - Nasdaq
BioNexus Gene Lab Corp SEC 10-K Report - TradingView
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory - The Manila Times
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational - Bluefield Daily Telegraph
BioNexus Slashes Losses by 39%: Inside the Biotech's Strategic Pivot to Blockchain and AI - Stock Titan
3 Penny Stocks to Watch Now, 4/15/25 - TipRanks
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
BioNexus Gene Lab Corp: Surge Insights - timothysykes.com
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Why BioNexus Gene Stock Jumps 55% in Premarket Trading - Own Snap
BioNexus Gene Lab enacts reverse stock split - Investing.com
BioNexus Gene Lab enacts reverse stock split By Investing.com - Investing.com India
BGLC stock touches 52-week high of $2.35 amid market fluctuations - Investing.com Australia
BGLC stock touches 52-week high of $2.35 amid market fluctuations By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Thursday's Intraday Session - Benzinga
BioNexus Gene Lab announces reverse stock split - Investing.com Australia
BioNexus Gene Lab announces reverse stock split By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Monday's After-Market Session - Benzinga
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):